TTR and cancer: Although albumin/prealbumin, and fibrinogen abnormalities are well-documented prognostic markers in cancer patients, not all cancer patients suffer from deficiencies of albumin/prealbumin and an overabundance of fibrinogen; some patients only have an albumin/prealbumin deficiency or only a fibrinogen overabundance.